期刊文献+

术前不同新辅助化疗方案对局部晚期宫颈癌患者治疗效果的影响 被引量:4

Effect of different preoperative neoadjuvant chemotherapy regimens on the treatment of patients with locally advanced cervical cancer
在线阅读 下载PDF
导出
摘要 目的探讨术前不同新辅助化疗方案对局部晚期宫颈癌患者治疗效果的影响。方法选取2015年7月~2017年7月我院收治的84例局部晚期宫颈癌患者作为研究对象,按照随机数字表法分为对照组和研究组,每组各42例。对照组患者在术前采用顺铂+紫杉醇(TP)方案进行新辅助化疗,研究组患者则采用顺铂+多西他赛(DP)方案进行术前新辅助化疗。比较两组患者的临床效果和不良反应情况。结果两组患者的治疗总有效率比较,差异无统计学意义(P>0.05);研究组患者的骨髓抑制、胃肠道反应、神经毒性以及变态反应等发生率均低于对照组,差异有统计学意义(P<0.05);两组患者的肝肾损伤发生率比较,差异无统计学意义(P>0.05)。结论顺铂联合紫杉醇与顺铂联合多西他赛两种术前新辅助化疗方案均能有效控制局部病灶,两者治疗效果相近,顺铂联合多西他赛方案能降低患者的不良反应发生率,安全性更好,值得临床推广应用。 Objective To investigate the effect of different preoperative neoadjuvant chemotherapy regimens on the treatment of patients with locally advanced cervical cancer.Methods A total of 84 patients with locally advanced cervical cancer admitted to our hospital from July 2015 to July 2017 were selected as the study subjects,they were divided into control group and research group according to random number table method,with 42 cases in each group.The control group received neoadjuvant chemotherapy with Cisplatin plus Paclitaxel(TP)before operation,while the study group received neoadjuvant chemotherapy with Cisplatin plus Docetaxel(DP)before operation.The clinical effects and adverse reactions of the two groups were compared.Results There was no significant difference in the total effective rate between the two groups(P>0.05).The incidence of bone marrow suppression,gastrointestinal reactions,neurotoxicity and allergic reactions in the study group were lower than those in the control group,the differences were significant(P<0.05).There was no significant difference in the incidence of liver and kidney injury between the two groups(P>0.05).Conclusion Cisplatin combined with Paclitaxel and Cisplatin combined with Docetaxel can effectively control local lesions.The therapeutic effect of both regimens is similar.Cisplatin combined with docetaxel can reduce the incidence of adverse reactions in patients with better safety,which is worthy of clinical application.
作者 冯秀英 王华伟 FENG Xiu-ying;WANG Hua-wei(Medical Examination Center,the 155^th Central Hospital of People′s Liberation Army,He′nan Province,Kaifeng 475000,China)
出处 《中国当代医药》 2019年第11期74-76,共3页 China Modern Medicine
关键词 局部晚期宫颈癌 新辅助化疗 顺铂 多西他赛 紫衫醇 临床疗效 Locally advanced cervical cancer Neoadjuvant chemotherapy Cisplatin Docetaxel Purpurol Clinical efficacy
  • 相关文献

参考文献15

二级参考文献120

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1621
  • 2李子庭,张志毅.子宫颈癌的变迁与治疗的策略[J].上海医学,2004,27(9):626-628. 被引量:5
  • 3糜若然,陈星.宫颈癌新辅助化疗的评价[J].国外医学(妇产科学分册),2006,33(1):61-63. 被引量:22
  • 4程晓东,吕卫国,叶枫,陈怀增,谢幸.局部晚期子宫颈癌新辅助化疗价值的评估[J].中华妇产科杂志,2006,41(2):95-98. 被引量:66
  • 5刘莉,宋水勤,张国楠,石宇,徐世强,刘红.小于35岁子宫颈癌患者213例治疗与预后分析[J].现代妇产科进展,2007,16(4):281-284. 被引量:8
  • 6Zannoni GF, Vellone VG, Carbone A. Morphological effects of radiochemotherapy on cervical carcinoma:a morphological study of 50 cases of hysterectomy specimens after neoad1 juvant treatment[J]. Int J Gynecol Pathol, 2008,27 (2): 274-281.
  • 7Loizzi V,Cormio G,Vicino M, et al. Neoadjuvant chemo therapy:an alternative option of treatment for locally ad vanced cervical eancer[J]. Gynecol Obstet Invest,2008,65 (2) :96- 103.
  • 8Petsuksiri J ,Chansilpa Y, Therasakvichya S, et al. Treat- ment options in bulky stage IB cervical carcinoma[J]. Int J Gynecol Cancer,2008,18(6) :1153-1162.
  • 9Manci N, Marchetti C, Di Tucci C, et al. A prospective phase Ⅱ study of topotecan (Hycamtin?) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer[J]. Gynecol Oncol,2011,122(2) :285-290.
  • 10Mori T, Hosokawa K, Sawada M, et al. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterecto my for locally advanced cervical cancer: long term results [J]. Int J Gynecol Cancer,2010,20(4) :611-616.

共引文献176

同被引文献45

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部